Ryan David Laschober, MD - Medicare Family Practice in Waco, TX

Ryan David Laschober, MD is a medicare enrolled "Family Medicine" physician in Waco, Texas. He went to University Of Arkansas College Of Medicine and graduated in 2013 and has 11 years of diverse experience with area of expertise as Family Practice. He is a member of the group practice Heart Of Texas Community Health Center, Inc. and his current practice location is 1600 Providence Drive, Waco, Texas. You can reach out to his office (for appointments etc.) via phone at (254) 313-4200.

Ryan David Laschober is licensed to practice in Texas (license number Q1655) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1861831034.

Contact Information

Ryan David Laschober, MD
1600 Providence Drive,
Waco, TX 76707
(254) 313-4200
(254) 313-4531



Physician's Profile

Full NameRyan David Laschober
GenderMale
SpecialityFamily Practice
Experience11 Years
Location1600 Providence Drive, Waco, Texas
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Ryan David Laschober attended and graduated from University Of Arkansas College Of Medicine in 2013
  NPI Data:
  • NPI Number: 1861831034
  • Provider Enumeration Date: 06/20/2013
  • Last Update Date: 06/15/2016
  Medicare PECOS Information:
  • PECOS PAC ID: 0749507499
  • Enrollment ID: I20150318000892

Medical Identifiers

Medical identifiers for Ryan David Laschober such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1861831034NPI-NPPES
344053901MedicaidTX

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine BP10047964 (Texas)Secondary
207Q00000XFamily Medicine Q1655 (Texas)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Heart Of Texas Community Health Center, Inc.115337024295

News Archive

Nymox Pharmaceutical announces new positive results from long term outcome study of NX-1207 for BPH

Nymox Pharmaceutical Corporation today announced new 2010 positive results from a long term outcome study of NX-1207 for benign prostatic hyperplasia (BPH). The study evaluated symptomatic progress of U.S. patients involved in the Company's NX02-0012 and NX02-0013 Phase 1-2 studies of NX-1207 initially undertaken in 2003. Patients treated with NX-1207 were followed-up on an unselected and as available basis and assessed for symptomatic improvement, treatment outcomes, and durability of efficacy 6 ½ years after a single treatment with NX-1207.

Medicaid expansions unlikely to have contributed to rise in drug overdose deaths

The United States in recent years has increased healthcare access by broadening Medicaid coverage, but some worry that these Medicaid expansions lead to more abuse of prescription painkillers and thus worsen the opioid epidemic.

Phase 3 trial: Cabazitaxel improves survival in patients with metastatic hormone-refractory prostate cancer

Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.

National Journal examines USAID administrator nominee's experience, prospects at the Agency

The National Journal looks at the professional background of Rajiv Shah, President Barack Obama's nominee to be the USAID administrator. "As Rajiv Shah prepares to lead the U.S. Agency for International Development, former colleagues, lobbyists and current and past administration officials paint a picture of a man with dizzying brainpower and social intelligence who has won over skeptics time and again.

New book on clinical laboratory mycological identification

A new edition of the definitive practical resource for laboratory identification of fungal infections is now available. "The fully revised Medically Important Fungi: A Guide to Identification, 5th Edition," published by ASM Press, offers step-by-step guidance and textual descriptions that allow both novice and experienced lab technologists to accurately distinguish between fungi that display similar characteristics.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Ryan David Laschober allows following entities to bill medicare on his behalf.
Entity NameMclennan County Medical Education And Research Foundation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1689651440
PECOS PAC ID: 0042205155
Enrollment ID: O20040419000208

News Archive

Nymox Pharmaceutical announces new positive results from long term outcome study of NX-1207 for BPH

Nymox Pharmaceutical Corporation today announced new 2010 positive results from a long term outcome study of NX-1207 for benign prostatic hyperplasia (BPH). The study evaluated symptomatic progress of U.S. patients involved in the Company's NX02-0012 and NX02-0013 Phase 1-2 studies of NX-1207 initially undertaken in 2003. Patients treated with NX-1207 were followed-up on an unselected and as available basis and assessed for symptomatic improvement, treatment outcomes, and durability of efficacy 6 ½ years after a single treatment with NX-1207.

Medicaid expansions unlikely to have contributed to rise in drug overdose deaths

The United States in recent years has increased healthcare access by broadening Medicaid coverage, but some worry that these Medicaid expansions lead to more abuse of prescription painkillers and thus worsen the opioid epidemic.

Phase 3 trial: Cabazitaxel improves survival in patients with metastatic hormone-refractory prostate cancer

Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.

National Journal examines USAID administrator nominee's experience, prospects at the Agency

The National Journal looks at the professional background of Rajiv Shah, President Barack Obama's nominee to be the USAID administrator. "As Rajiv Shah prepares to lead the U.S. Agency for International Development, former colleagues, lobbyists and current and past administration officials paint a picture of a man with dizzying brainpower and social intelligence who has won over skeptics time and again.

New book on clinical laboratory mycological identification

A new edition of the definitive practical resource for laboratory identification of fungal infections is now available. "The fully revised Medically Important Fungi: A Guide to Identification, 5th Edition," published by ASM Press, offers step-by-step guidance and textual descriptions that allow both novice and experienced lab technologists to accurately distinguish between fungi that display similar characteristics.

Read more Medical News

› Verified 4 days ago

Entity NameHeart Of Texas Community Health Center, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1568191492
PECOS PAC ID: 1153370242
Enrollment ID: O20050114000813

News Archive

Nymox Pharmaceutical announces new positive results from long term outcome study of NX-1207 for BPH

Nymox Pharmaceutical Corporation today announced new 2010 positive results from a long term outcome study of NX-1207 for benign prostatic hyperplasia (BPH). The study evaluated symptomatic progress of U.S. patients involved in the Company's NX02-0012 and NX02-0013 Phase 1-2 studies of NX-1207 initially undertaken in 2003. Patients treated with NX-1207 were followed-up on an unselected and as available basis and assessed for symptomatic improvement, treatment outcomes, and durability of efficacy 6 ½ years after a single treatment with NX-1207.

Medicaid expansions unlikely to have contributed to rise in drug overdose deaths

The United States in recent years has increased healthcare access by broadening Medicaid coverage, but some worry that these Medicaid expansions lead to more abuse of prescription painkillers and thus worsen the opioid epidemic.

Phase 3 trial: Cabazitaxel improves survival in patients with metastatic hormone-refractory prostate cancer

Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.

National Journal examines USAID administrator nominee's experience, prospects at the Agency

The National Journal looks at the professional background of Rajiv Shah, President Barack Obama's nominee to be the USAID administrator. "As Rajiv Shah prepares to lead the U.S. Agency for International Development, former colleagues, lobbyists and current and past administration officials paint a picture of a man with dizzying brainpower and social intelligence who has won over skeptics time and again.

New book on clinical laboratory mycological identification

A new edition of the definitive practical resource for laboratory identification of fungal infections is now available. "The fully revised Medically Important Fungi: A Guide to Identification, 5th Edition," published by ASM Press, offers step-by-step guidance and textual descriptions that allow both novice and experienced lab technologists to accurately distinguish between fungi that display similar characteristics.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ryan David Laschober is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Ryan David Laschober, MD
1600 Providence Dr,
Waco, TX 76707-2261

Ph: (254) 313-4200
Ryan David Laschober, MD
1600 Providence Drive,
Waco, TX 76707

Ph: (254) 313-4200

News Archive

Nymox Pharmaceutical announces new positive results from long term outcome study of NX-1207 for BPH

Nymox Pharmaceutical Corporation today announced new 2010 positive results from a long term outcome study of NX-1207 for benign prostatic hyperplasia (BPH). The study evaluated symptomatic progress of U.S. patients involved in the Company's NX02-0012 and NX02-0013 Phase 1-2 studies of NX-1207 initially undertaken in 2003. Patients treated with NX-1207 were followed-up on an unselected and as available basis and assessed for symptomatic improvement, treatment outcomes, and durability of efficacy 6 ½ years after a single treatment with NX-1207.

Medicaid expansions unlikely to have contributed to rise in drug overdose deaths

The United States in recent years has increased healthcare access by broadening Medicaid coverage, but some worry that these Medicaid expansions lead to more abuse of prescription painkillers and thus worsen the opioid epidemic.

Phase 3 trial: Cabazitaxel improves survival in patients with metastatic hormone-refractory prostate cancer

Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.

National Journal examines USAID administrator nominee's experience, prospects at the Agency

The National Journal looks at the professional background of Rajiv Shah, President Barack Obama's nominee to be the USAID administrator. "As Rajiv Shah prepares to lead the U.S. Agency for International Development, former colleagues, lobbyists and current and past administration officials paint a picture of a man with dizzying brainpower and social intelligence who has won over skeptics time and again.

New book on clinical laboratory mycological identification

A new edition of the definitive practical resource for laboratory identification of fungal infections is now available. "The fully revised Medically Important Fungi: A Guide to Identification, 5th Edition," published by ASM Press, offers step-by-step guidance and textual descriptions that allow both novice and experienced lab technologists to accurately distinguish between fungi that display similar characteristics.

Read more News

› Verified 4 days ago


Family Medicine Doctors in Waco, TX

Allison L Hulme, MD
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 1600 Providence Dr, Waco, TX 76707
Phone: 254-750-8200    Fax: 254-750-8326
Timothy Martindale, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 7104 New Sanger Rd, Waco, TX 76712
Phone: 254-741-1113    Fax: 254-741-1342
Dr. Brian Douglas Bull, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 851 North Loop 340, Waco, TX 76705
Phone: 254-202-7500    Fax: 254-202-7599
Dr. Matthew R Porter, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 600 W. State Hwy 6, Waco, TX 76712
Phone: 254-313-6700    Fax: 254-313-4531
Lianda Mirella Martinez,
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 600 Franklin Ave, Suite B-c, Waco, TX 76701
Phone: 254-537-6590    Fax: 254-537-6599
Jacob Lutgen,
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1600 Providence Dr, Waco, TX 76707
Phone: 254-313-4200    
Dr. Aman A Shah, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712
Phone: 254-202-2000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.